The US Food and Drug Administration (FDA) has granted 510(k) clearance to Olympus’ 3D laparoscopic surgical video system.
The Endoeye Flex 3D system, which the company claims is the world’s only articulating HD 3D laparoscopic platform, is expected to reduce surgical errors and improve the speed, accuracy and precision of surgical events when compared with conventional 2D surgical systems.
The system also restores natural 3D vision and depth perception when performing laparoscopic procedures.
Loma Linda University Health System surgery assistant professor Dr Marcos Michellotti said while performing laparoscopic surgical cases, the Olympus system enabled in suturing, accurately identifying tissue planes and other precision surgical tasks.
"In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3D without losing the important visual horizon," Michellotti added.
"This is not possible with traditional fixed angle laparoscopes."
The device’s modular design also allows clinicians to add an existing Olympus Evis Exera III universal imaging system, thus helping to reduce the investment necessary to add 3D capability, according to the company.
Olympus medical systems group president Luke Calcraft said the HD 3D system is designed for surgeons who need the precision, resolution, and depth perception of 3D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology.
"We are leading the way with new innovations to help our customers realize the clinical efficacy and cost effectiveness required under Accountable Care," Calcraft said.
Image: Olympus’ Endoeye Flex 3D laparoscope improves the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing. Photo: Courtesy of PR Newswire.